Epstein-Barr Virus Infections
"Epstein-Barr Virus Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).
| Descriptor ID |
D020031
|
| MeSH Number(s) |
C02.256.466.313 C02.928.313
|
| Concept/Terms |
Epstein-Barr Virus Infections- Epstein-Barr Virus Infections
- Epstein Barr Virus Infections
- EBV Infections
- Infections, Epstein-Barr Virus
- Human Herpesvirus 4 Infections
- Herpesvirus 4 Infections, Human
- Epstein-Barr Virus Infection
- Epstein Barr Virus Infection
- Infection, Epstein-Barr Virus
- Virus Infection, Epstein-Barr
- Virus Infections, Epstein-Barr
- Infections, EBV
- EBV Infection
- Infection, EBV
- Human Herpes Virus 4 Infections
|
Below are MeSH descriptors whose meaning is more general than "Epstein-Barr Virus Infections".
Below are MeSH descriptors whose meaning is more specific than "Epstein-Barr Virus Infections".
This graph shows the total number of publications written about "Epstein-Barr Virus Infections" by people in this website by year, and whether "Epstein-Barr Virus Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 1 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 3 | 1 | 4 |
| 2002 | 4 | 4 | 8 |
| 2003 | 8 | 0 | 8 |
| 2004 | 3 | 0 | 3 |
| 2005 | 4 | 3 | 7 |
| 2006 | 3 | 2 | 5 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 3 | 4 |
| 2009 | 5 | 1 | 6 |
| 2010 | 4 | 2 | 6 |
| 2011 | 8 | 3 | 11 |
| 2012 | 2 | 0 | 2 |
| 2013 | 8 | 2 | 10 |
| 2014 | 3 | 1 | 4 |
| 2015 | 5 | 0 | 5 |
| 2016 | 3 | 1 | 4 |
| 2017 | 5 | 0 | 5 |
| 2018 | 2 | 2 | 4 |
| 2019 | 4 | 1 | 5 |
| 2020 | 5 | 2 | 7 |
| 2021 | 7 | 0 | 7 |
| 2022 | 8 | 0 | 8 |
| 2023 | 8 | 2 | 10 |
| 2024 | 4 | 2 | 6 |
| 2025 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Epstein-Barr Virus Infections" by people in Profiles.
-
Circulating Epstein-Barr Virus Antibody Levels as a Biomarker of Socioecological Adversity in Amazonian Ecuador. Am J Hum Biol. 2025 May; 37(5):e70063.
-
Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas. Blood Adv. 2025 Apr 08; 9(7):1658-1669.
-
TGF? links EBV to multisystem inflammatory syndrome in children. Nature. 2025 Apr; 640(8059):762-771.
-
Navigating Epstein-Barr Virus (EBV) and Post-Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Liver Transplantation: Current Knowledge and Strategies for Treatment and Surveillance. Viruses. 2025 02 13; 17(2).
-
Burkitt lymphoma. Hum Pathol. 2025 Feb; 156:105703.
-
EBV and post-transplant lymphoproliferative disorder: a complex relationship. Hematology Am Soc Hematol Educ Program. 2024 12 06; 2024(1):728-735.
-
From the archives of MD Anderson Cancer Center: EBV-positive fibrin-associated large B-cell lymphoma in an ovarian leiomyoma with cystic degeneration: A case report and discussion of differential diagnosis. Ann Diagn Pathol. 2025 Feb; 74:152397.
-
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial. Ann Oncol. 2024 Dec; 35(12):1181-1190.
-
Cotargeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphoma. Blood Adv. 2024 07 09; 8(13):3360-3371.
-
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk-stratification, and management. Am J Hematol. 2024 Oct; 99(10):2002-2015.